<VariationArchive VariationID="498226" VariationName="NM_000275.3(OCA2):c.2177_2181del (p.Val726fs)" VariationType="Deletion" Accession="VCV000498226" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2018-04-02" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="489650" VariationID="498226">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.3(OCA2):c.2177_2181del (p.Val726fs)</Name>
      <CanonicalSPDI>NC_000015.10:27871216:CAGGACA:CA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27871217" stop="27871221" display_start="27871217" display_stop="27871221" variantLength="5" positionVCF="27871216" referenceAlleleVCF="CCAGGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28116363" stop="28116367" display_start="28116363" display_stop="28116367" variantLength="5" positionVCF="28116362" referenceAlleleVCF="CCAGGA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V702fs</ProteinChange>
      <ProteinChange>V726fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.27871219_27871223del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.27871219_27871223del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28116365_28116369del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28116365_28116369del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.1" sequenceAccession="NG_009846" sequenceVersion="1" change="g.233092_233096del">
            <Expression>NG_009846.1:g.233092_233096del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.3" sequenceAccession="NM_000275" sequenceVersion="3" change="c.2177_2181del" MANESelect="true">
            <Expression>NM_000275.3:c.2177_2181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000266.2" sequenceAccession="NP_000266" sequenceVersion="2" change="p.Val726fs">
            <Expression>NP_000266.2:p.Val726fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300984.2" sequenceAccession="NM_001300984" sequenceVersion="2" change="c.2105_2109del">
            <Expression>NM_001300984.2:c.2105_2109del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287913.1" sequenceAccession="NP_001287913" sequenceVersion="1" change="p.Val702fs">
            <Expression>NP_001287913.1:p.Val702fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.2" sequenceAccession="NM_000275" sequenceVersion="2" change="c.2177_2181del5">
            <Expression>NM_000275.2:c.2177_2181del5</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7438713" DB="ClinGen" />
        <XRef Type="rs" ID="771620099" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.3(OCA2):c.2177_2181del (p.Val726fs) AND not provided" Accession="RCV000592782" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.2177_2181del (p.Val726fs) AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV001797757" Version="2">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.2177_2181del (p.Val726fs) AND SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES" Accession="RCV004568314" Version="1">
        <ClassifiedConditionList TraitSetID="252">
          <ClassifiedCondition DB="MedGen" ID="C1856895">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.2177_2181del (p.Val726fs) AND OCA2-related disorder" Accession="RCV003424163" Version="4">
        <ClassifiedConditionList TraitSetID="89105">
          <ClassifiedCondition>OCA2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-17" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-04-02" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19865097</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21541274</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7762554</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OCA2</URL>
        </Citation>
        <DescriptionHistory Dated="2024-06-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="252" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Skin/hair/eye pigmentation, variation in, 1</ElementValue>
                <XRef ID="Skin-hair-eye+pigmentation%2C+variation+in%2C+1/9304" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BROWN EYE COLOR 2</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR 3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR, BLUE/NONBLUE</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR, BROWN/BLUE</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HAIR COLOR 3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BEY2</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EYCL3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HCL3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SHEP1</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <XRef ID="C1856895" DB="MedGen" />
              <XRef Type="MIM" ID="227220" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89105" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OCA2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">OCA2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1375529" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="56166_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000703128" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="-" referenceAllele="CAGGA" start="28116363" stop="28116367" variantLength="5" />
            <GeneLocation>NM_000275.2:Ex21</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD952150" />
            <XRef DB="dbSNP" ID="771620099" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OCA2</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4004266" SubmissionDate="2021-12-22" DateLastUpdated="2021-12-25" DateCreated="2021-12-25">
        <ClinVarSubmissionID localKey="NM_000275.3:c.2177_2181del|OMIM:203200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002040564" DateUpdated="2021-12-25" DateCreated="2021-12-25" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.3:c.2177_2181del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10837152</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7700742" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3379711|OCA2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004118323" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The OCA2 c.2177_2181del5 variant is predicted to result in a frameshift and premature protein termination (p.Val726Glyfs*13). This variant has been reported in a parent of an oculocutaneous albinism affected child (child was not available for testing; Spritz et al. 1995. PubMed ID: 7762554, reported as V726-L727delGTCCT). This variant is reported in 0.024% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-28116362-CCAGGA-C). Frameshift variants in OCA2 are expected to be pathogenic. Given the evidence, we interpret c.2177_2181del (p.Val726Glyfs*13) as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.2:c.2177_2181del5</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OCA2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111293" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4920894|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585647" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19865097</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21541274</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7762554</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val726Glyfs*13) in the OCA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OCA2 are known to be pathogenic (PMID: 19865097, 21541274). This variant is present in population databases (rs771620099, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with a family history of oculocutaneous albinism (PMID: 7762554). This variant is also known as V726-L727delGTCCT. ClinVar contains an entry for this variant (Variation ID: 498226). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.28116363_28116367del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9812520" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000275.3:c.2177_2181del|OMIM:227220" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005053782" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.3:c.2177_2181del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227220" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3111293" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1375529" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7700742" TraitType="Disease" MappingType="Name" MappingValue="OCA2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="OCA2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4004266" TraitType="Disease" MappingType="XRef" MappingValue="203200" MappingRef="OMIM">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9812520" TraitType="Disease" MappingType="XRef" MappingValue="227220" MappingRef="OMIM">
        <MedGen CUI="C1856895" Name="SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

